MMED · Nasdaq, Nasdaq · CIK 0002062583

MiniMed Group, Inc.

MiniMed Group, Inc.’s most recent SEC filing in our snapshot is a Form SCHEDULE 13G filed on Oct 22, 2026. In fiscal 2026 (year ended Apr 24, 2026) it reported revenue of $3.1B and net income of -$333.0M, according to its XBRL data on EDGAR. Its EDGAR record lists 41 Form 4 insider filings from the 12 months before our last refresh.

SEC EDGAR snapshot updated Oct 27, 2026, 11:27 PM EDT. See all filings on sec.gov.

Revenue, FY2026
$3.1B
Net income, FY2026
-$333.0M
Form 4 filings on record, past 12 months
41

Company overview

Legal name (as filed)
MiniMed Group, Inc.
Tickers
MMED, MMEDV
SEC Central Index Key (CIK)
0002062583
Business address
NORTHRIDGE, CA
State or country of incorporation
DE
Fiscal year ends
December 31
SEC filer category
Non-accelerated filer
Position in SEC ticker list
#1319 of the 3,000 companies we track

Five-year financial highlights

Full-year figures from MiniMed Group, Inc.’s annual reports, as tagged in XBRL and published by the SEC. Amounts are in U.S. dollars; the fiscal year is named for the calendar year in which it ends.

Revenue
$2.5BFY2024$2.7BFY2025$3.1BFY2026
Net income
-$112.0MFY2024-$213.0MFY2025-$333.0MFY2026
MMED annual results
ItemFY2024
ended Apr 26, 2024		FY2025
ended Apr 25, 2025		FY2026
ended Apr 24, 2026
Revenue$2.5B$2.7B$3.1B
Net income-$112.0M-$213.0M-$333.0M
Diluted EPS-$0.44-$0.84-$1.30
Total assets—$4.2B$4.6B
Cash and equivalents$54.0M$11.0M$298.0M

XBRL tags used: revenue = RevenueFromContractWithCustomerExcludingAssessedTax; netIncome = NetIncomeLoss; assets = Assets; eps = EarningsPerShareDiluted; cash = CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents. EPS is shown as originally reported for each year and may not be adjusted for later stock splits. A dash means the company did not report that item in a form we could match.

How to read these numbers

Revenue is the money a company brings in from selling its products and services; net income is what is left after all expenses, interest and taxes. Diluted EPS spreads net income across every share that could exist if options and convertible securities were exercised. Total assets and cash are balance-sheet figures measured on the last day of the fiscal year. For the full story — segment results, one-time charges, guidance — read Management’s Discussion and Analysis in the Form 10-K.

Latest key reports

The most recent filing of each major report type, even if it falls outside the 40 newest filings below.

MMED latest annual, quarterly, current and proxy reports
FiledFormWhat it isOriginal
Jun 29, 202610-KAnnual report· period Apr 24, 2026Document · Index
Sep 8, 202610-QQuarterly report· period Jul 31, 2026Document · Index
Oct 16, 20268-KChange in control; Director or officer change; Regulation FD disclosure· period Oct 15, 2026Document · Index
Aug 21, 2026DEF 14ADefinitive proxy statement· period Oct 9, 2026Document · Index

Recent SEC filings

The 40 newest documents filed by or about MiniMed Group, Inc., by form type:

4 ×17425 ×88-K ×43 ×2SCHEDULE 13G ×1SCHEDULE 13G/A ×1EFFECT ×1424B3 ×1S-4 ×110-Q ×1ARS ×1DEFA14A ×1DEF 14A ×1
MMED recent filings
FiledFormWhat it isOriginal
Oct 22, 2026SCHEDULE 13GPassive beneficial ownership report (over 5%)Document · Index
Oct 19, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 15, 2026Document · Index
Oct 19, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 15, 2026Document · Index
Oct 19, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 15, 2026Document · Index
Oct 16, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 15, 2026Document · Index
Oct 16, 20263Initial statement of beneficial ownership· period Oct 15, 2026Document · Index
Oct 16, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 15, 2026Document · Index
Oct 16, 2026SCHEDULE 13G/APassive beneficial ownership report (over 5%)Document · Index
Oct 16, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 15, 2026Document · Index
Oct 16, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 15, 2026Document · Index
Oct 16, 20268-KChange in control; Director or officer change; Regulation FD disclosure· period Oct 15, 2026Document · Index
Oct 13, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 9, 2026Document · Index
Oct 13, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 9, 2026Document · Index
Oct 13, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 9, 2026Document · Index
Oct 13, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 9, 2026Document · Index
Oct 13, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 9, 2026Document · Index
Oct 13, 20268-KShareholder vote results· period Oct 9, 2026Document · Index
Oct 5, 2026EFFECTEFFECTDocument · Index
Oct 5, 20264Statement of changes in beneficial ownership (insider trade)· period Oct 1, 2026Document · Index
Oct 5, 2026424B3424B3Document · Index
Oct 1, 20263Initial statement of beneficial ownership· period Sep 25, 2026Document · Index
Sep 21, 2026425425Document · Index
Sep 21, 2026425425Document · Index
Sep 14, 2026425425Document · Index
Sep 14, 2026425425Document · Index
Sep 14, 2026425425Document · Index
Sep 14, 2026425425Document · Index
Sep 14, 2026425425Document · Index
Sep 14, 2026425425Document · Index
Sep 14, 2026S-4Registration statement for business combinationsDocument · Index
Sep 8, 202610-QQuarterly report· period Jul 31, 2026Document · Index
Sep 1, 20268-KResults of operations; Regulation FD disclosure· period Sep 1, 2026Document · Index
Aug 21, 2026ARSARS· period Apr 24, 2026Document · Index
Aug 21, 2026DEFA14AAdditional proxy soliciting materialsDocument · Index
Aug 21, 2026DEF 14ADefinitive proxy statement· period Oct 9, 2026Document · Index
Aug 5, 20268-KDirector or officer change· period Jul 30, 2026Document · Index
Aug 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 31, 2026Document · Index
Aug 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 31, 2026Document · Index
Aug 4, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 31, 2026Document · Index
Jul 29, 20264Statement of changes in beneficial ownership (insider trade)· period Jul 28, 2026Document · Index

Insider filing activity

41 Form 4 filings appear in MiniMed Group, Inc.’s EDGAR record between Oct 28, 2025 and our last refresh. Most are reports by the company’s own directors, officers and 10% owners, but EDGAR also lists a Form 4 under a company when the company itself is the insider — for example, when it owns more than 10% of another public company. Foreign private issuers’ own insiders generally do not file Form 4. A high count is not by itself a signal: many Form 4s report routine stock awards, tax withholding or sales under pre-arranged Rule 10b5-1 plans. Open each filing to see the transaction code, share count and price. What a Form 4 shows.

Other companies in Surgical & Medical Instruments & Apparatus

All 51 companies in Surgical & Medical Instruments & Apparatus· Companies headquartered in California

On Amazon

Popular tools for investors

As an Amazon Associate I earn from qualifying purchases.

Electronics Plaud Note Pro AI Voice Recorder An AI voice recorder that turns earnings calls and meetings into notes. View on Amazon → Electronics Amazon Kindle Paperwhite Signature Edition 32GB Read investing classics and long reports without eye strain. View on Amazon → Electronics Apple 2026 MacBook Air 13-inch Laptop A lightweight laptop for spreadsheets and filing research. View on Amazon →

Source

  • U.S. Securities and Exchange Commission, EDGAR submissions for CIK 0002062583 and XBRL company facts. MiniMed Group, Inc. on EDGAR.
  • Snapshot updated Oct 27, 2026, 11:27 PM EDT. The SEC does not endorse OpenFilings. Company names and tickers are used only to identify the filer; no logos are shown.

Not investment advice. This page summarizes public SEC filings for information only. Figures may contain errors or omissions; confirm everything in the original filing before relying on it.